— Know what they know.
Not Investment Advice
Also trades as: EVT.DE (XETRA) · $vol 3M · EVT.SW (SIX) · $vol 1M · 0IRF.IL (IOB) · $vol 0M · EVO (NASDAQ) · $vol 0M

EVOTF OTC

Evotec SE
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +7.7% 1Y: -8.1% 3Y: -59.9% 5Y: -83.2%
$6.69
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 56 · $1.2B mcap · 148M float · 0.0000% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$18M -50.0% ▼
5Y CAGR: -15.5%
Capital Expenditures
$132M +38.8% ▲
5Y CAGR: +32.9%
Free Cash Flow
-$114M +36.5% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$205M -313.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$6M$216M-$176M-$84M-$196M
Depreciation & Amort.$56M$68M$82M$93M$102M
Stock-Based Comp.$5M$8M$10M$10M$5M
Change in Working Capital-$37M-$19M$119M-$10M-$68M
Other Non-Cash Items$7M-$170M$160M$24M$174M
Operating Cash Flow$45M$122M$203M$36M$18M
— Investing Activities —
Capital Expenditures-$99M-$119M-$181M-$213M-$117M
Acquisitions (Net)-$34M-$21M-$80M-$20M$43M
Investment Purchases-$71M-$124M-$356M-$48M-$29M
Investment Sales$55M$27M$205M$260M$36M
Other Investing-$6M-$7M-$4M$8M-$3M
Investing Cash Flow-$155M-$244M-$416M-$13M-$71M
— Financing Activities —
Net Debt Issuance-$5M-$6M-$53M$85M-$152M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$2M-$5M-$6M-$13M-$9M
Financing Cash Flow$246M$398M-$52M$72M-$161M
Net Change in Cash$146M$277M-$284M$96M-$205M
Cash End of Period$423M$699M$415M$511M$306M
Free Cash Flow-$54M$3M$22M-$180M-$114M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms